Sh-Oligopeptide-9 for Hair Regrowth - Quick Reference Sheet
evipedia.ai
← Back

Sh-Oligopeptide-9 for Hair Regrowth

Created on 09/26/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Sh-Oligopeptide-9, a lab-made fragment of one of the body's own opioid-like signaling molecules sold as a moisturizing cosmetic ingredient in scalp serums, has never been tested for hair regrowth in people. Mouse studies point in opposite directions, and whether it passes through the scalp is unknown. Risks appear small and come mostly from the product formula; the larger consideration is months spent without treatments that have trial support. (Full Review)

Protocol

Typical label regimen
A few drops to about 1 mL, once or twice daily
Clean, dry scalp; massaged in, left on without rinsing. No standardized protocol; concentration rarely disclosed
Approach 2, add-on to tested treatment
Layered with minoxidil or finasteride
Regrowth effects of these confirmed in a meta-analysis; the serum's added contribution is untested
Time of day
Evening, after the last wash of the day
No timing data exist; allows several hours of undisturbed contact
Time to effect
Tested treatments
Months to a year
Time needed to separate from placebo; hair cycles are slow
Judging any scalp serum
At least 6 months
No Sh-Oligopeptide-9 hair data; photographs at baseline and 6 months give an objective stop rule

Benefits

Contraindications
  • Known allergy to any product ingredient (positive patch test or prior reaction to the formula)
  • Active scalp dermatitis, psoriasis flare, scalp infection or open wounds (any severity)
  • Pregnancy (all trimesters) and breastfeeding
  • Children and adolescents under 18 years
  • Scarring alopecia (e.g., lichen planopilaris, frontal fibrosing alopecia) or sudden patchy loss suggesting alopecia areata, as sole treatment
    •
Key Interactions
  • Topical retinoids (vitamin A–derived skin drugs; tretinoin, adapalene): Caution; raised irritation and dermatitis risk
  • Microneedling: Caution; irritation, infection and foreign-body skin reactions
  • Topical minoxidil (Rogaine): Monitor; layering adds scalp irritation
  • Over-the-counter antifungal shampoo (ketoconazole 1%): Monitor; additive scalp dryness and irritation
  • Topical hair supplements (caffeine, rosemary oil, copper peptide GHK-Cu, a copper-binding tripeptide): Monitor; additive effect and irritation risk
  • Oral biotin supplements (above 5 mg/day): Monitor; distorts thyroid and other lab results
  • Opioid antagonists (opioid receptor blockers; naltrexone, naloxone): Theoretical, low relevance
  • Over-the-counter enkephalinase inhibitor (a drug slowing enkephalin breakdown; racecadotril): Theoretical
  • 5α-reductase inhibitors (drugs blocking testosterone's conversion to dihydrotestosterone, the hormone that shrinks follicles; finasteride, dutasteride): No interaction expected
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Contact dermatitis from the product formula; forgone benefit of tested hair-loss treatments
    •
  • Speculative: Slowed follicle cell division; systemic opioid effects; residual inflammatory bacterial cell-wall fragments
    •

Monitoring

Marker Target Why
Hair density (phototrichogram, magnified scalp hair count) No established target; track change from own baseline Objective regrowth readout
Standardized scalp photographs No established target; track change from own baseline Visible coverage change
Ferritin 70–150 ng/mL Iron stores; low levels linked to shedding
TSH (thyroid-stimulating hormone) 0.5–2.5 mIU/L Screens thyroid-related shedding
25-hydroxyvitamin D 40–60 ng/mL Low levels associated with hair loss
Zinc (plasma) 90–120 µg/dL Deficiency causes shedding

Cadence: Baseline before starting; photographs and density counts at 3 and 6 months, then every 6 months while use continues; blood tests repeated only if baseline values were abnormal or shedding worsens

Qualitative Assessment

  • Shedding: hairs on pillow, in the shower drain and on the brush, counted on standardized wash days
  • Scalp comfort: itch, redness, flaking or stinging after application
  • Hair feel: softness, breakage and shaft thickness to the touch
  • Styling coverage: how easily thinning areas can be concealed
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.